Cargando…

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

Finding novel targets in non-small cell lung cancer (NSCLC) is highly needed and identification of synthetic lethality between two genes is a new approach to target NSCLC. We previously found that TMPRSS4 promotes NSCLC growth and constitutes a prognostic biomarker. Here, through large-scale analyse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villalba, Maria, Redin, Esther, Exposito, Francisco, Pajares, Maria Jose, Sainz, Cristina, Hervas, David, Guruceaga, Elizabeth, Diaz-Lagares, Angel, Cirauqui, Cristina, Redrado, Miriam, Valencia, Karmele, de Andrea, Carlos, Jantus-Lewintre, Eloisa, Camps, Carlos, Lopez-Lopez, Rafael, Lahoz, Agustin, Montuenga, Luis, Pio, Ruben, Sandoval, Juan, Calvo, Alfonso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817908/ https://www.ncbi.nlm.nih.gov/pubmed/31659178 http://dx.doi.org/10.1038/s41598-019-51066-3

Ejemplares similares

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019)

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
por: Palanca-Ballester, Cora, et al.
Publicado: (2021)

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients
por: Villalba, Maria, et al.
Publicado: (2016)

MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014)

Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
por: Valencia, Karmele, et al.
Publicado: (2022)

SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation
por: Redin, Esther, et al.
Publicado: (2021)

Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma
por: Dikova, Valentina, et al.
Publicado: (2021)

On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2023)

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology
por: Larzabal, L, et al.
Publicado: (2011)

Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
por: Otegui, Nerea, et al.
Publicado: (2023)

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
por: Gallach, Sandra, et al.
Publicado: (2017)

TMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis
por: Larzabal, L, et al.
Publicado: (2014)

Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2016)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer
por: Moreno-Manuel, Andrea, et al.
Publicado: (2020)

Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients
por: Dong, Ning, et al.
Publicado: (2021)

Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer
por: Valles, Iñaki, et al.
Publicado: (2012)

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
por: Molina-Pinelo, Sonia, et al.
Publicado: (2016)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
por: Usó, Marta, et al.
Publicado: (2016)

Biological insights in non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Zhang, Feiyu, et al.
Publicado: (2021)

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy
por: Quintanal-Villalonga, Álvaro, et al.
Publicado: (2020)

Exosomes in Liquid Biopsy: The Nanometric World in the Pursuit of Precision Oncology
por: Valencia, Karmele, et al.
Publicado: (2021)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas
por: Bernaldo de Quirós, Sandra, et al.
Publicado: (2013)

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2022)

Circulating Levels of the Interferon-γ-Regulated Chemokines CXCL10/CXCL11, IL-6 and HGF Predict Outcome in Metastatic Renal Cell Carcinoma Patients Treated with Antiangiogenic Therapy
por: Esteban, Emilio, et al.
Publicado: (2021)

BMI1, ATM and DDR
por: Lin, Xiaozeng, et al.
Publicado: (2015)

Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
por: Terai, Hideki, et al.
Publicado: (2015)

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
por: Elkamhawy, Ahmed, et al.
Publicado: (2021)

Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia
por: García-Ortí, Laura, et al.
Publicado: (2012)

Cell-ECM interactions control DDR
por: Dickreuter, Ellen, et al.
Publicado: (2015)

SPACE: an algorithm to predict and quantify alternatively spliced isoforms using microarrays
por: Anton, Miguel A, et al.
Publicado: (2008)

DSTYK inhibition increases the sensitivity of lung cancer cells to T cell–mediated cytotoxicity
por: Valencia, Karmele, et al.
Publicado: (2022)

Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
por: Wasinski, Benjamin, et al.
Publicado: (2020)

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2019)

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021)

DdrA, DdrD, and PprA: Components of UV and Mitomycin C Resistance in Deinococcus radiodurans R1
por: Selvam, Kathiresan, et al.
Publicado: (2013)

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype
por: Larrayoz, Marta, et al.
Publicado: (2014)

DDR1 key for cancer cell escape
por: Leslie, Mitch
Publicado: (2014)

Inside the hypoxic tumour: reprogramming of the DDR and radioresistance
por: Begg, Katheryn, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4hlotbvsma0hvddqj15net6dcg